During the past decade, New York Blood Ctr conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "New York Blood Ctr" are "HIV Infections" (5 trials) and "HIV Seronegativity" (1 trials). Many other conditions were trialed in "New York Blood Ctr" in a lesser frequency.

Most popular intervention types in "New York Blood Ctr" are "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Behavioral intervention" (1 trials), "MN rgp120/HIV-1 and GNE8 rgp120/HIV-1" (1 trials), "Risk-reduction counseling" (1 trials) and "Vaccine preparedness" (1 trials). Other intervention names were less common.

The vast majority of trials in "New York Blood Ctr" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "New York Blood Ctr". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in New York Blood Ctr, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in New York Blood Ctr, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".